Alana Harris Dent

Array ( [id] => 8749471 [patent_doc_number] => 08415304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Sparc and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/295068 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16130 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12295068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385263 [patent_doc_number] => 20090226508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Methods And Materials For Immunization Against Cancer' [patent_app_type] => utility [patent_app_number] => 12/225140 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14323 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226508.pdf [firstpage_image] =>[orig_patent_app_number] => 12225140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199127 [patent_doc_number] => 20070298445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Cancer Therapeutic' [patent_app_type] => utility [patent_app_number] => 11/682184 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 27588 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298445.pdf [firstpage_image] =>[orig_patent_app_number] => 11682184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909195 [patent_doc_number] => 20080019961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Hedgehog signaling pathway antagonist cancer treatment' [patent_app_type] => utility [patent_app_number] => 11/708885 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20067 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019961.pdf [firstpage_image] =>[orig_patent_app_number] => 11708885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6219994 [patent_doc_number] => 20100055089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Methods for Inhibition of Lymphangiogenesis and Tumor Metastasis' [patent_app_type] => utility [patent_app_number] => 12/223380 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 20526 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055089.pdf [firstpage_image] =>[orig_patent_app_number] => 12223380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 80640 [patent_doc_number] => 07744880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Cell growth inhibitors containing anti-glypican 3 antibody' [patent_app_type] => utility [patent_app_number] => 11/702780 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7535 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/744/07744880.pdf [firstpage_image] =>[orig_patent_app_number] => 11702780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5065171 [patent_doc_number] => 20070226813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'METHODS OF SCREENING FOR ANTITUMOR AGENTS' [patent_app_type] => utility [patent_app_number] => 11/668873 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10064 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20070226813.pdf [firstpage_image] =>[orig_patent_app_number] => 11668873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5071785 [patent_doc_number] => 20070192887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'TAT-042 and methods of assessing and treating cancer' [patent_app_type] => utility [patent_app_number] => 11/699833 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 65279 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20070192887.pdf [firstpage_image] =>[orig_patent_app_number] => 11699833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5323453 [patent_doc_number] => 20090061443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Diagnostic and Therapeutic Targets for Leukemia' [patent_app_type] => utility [patent_app_number] => 12/161482 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14701 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061443.pdf [firstpage_image] =>[orig_patent_app_number] => 12161482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315910 [patent_doc_number] => 20090280508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Methods and Reagents for Preparing and Using Immunological Agents Specific for P-Glycoprotein' [patent_app_type] => utility [patent_app_number] => 11/566989 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 9288 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280508.pdf [firstpage_image] =>[orig_patent_app_number] => 11566989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545965 [patent_doc_number] => 20090155842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'PROGNOSTIC ASSAY FOR METACHRONOUS COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/095300 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6365 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155842.pdf [firstpage_image] =>[orig_patent_app_number] => 12095300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193458 [patent_doc_number] => 20070081942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Gene differentially expressed in breast and bladder cancer, and encoded polypeptides' [patent_app_type] => utility [patent_app_number] => 11/601669 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 67169 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20070081942.pdf [firstpage_image] =>[orig_patent_app_number] => 11601669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760082 [patent_doc_number] => 08420603 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'SPARC and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/599100 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16295 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11599100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7692205 [patent_doc_number] => 20070231828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Methods of predicting behavior of cancers' [patent_app_type] => utility [patent_app_number] => 11/594281 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17287 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231828.pdf [firstpage_image] =>[orig_patent_app_number] => 11594281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154886 [patent_doc_number] => 20070037769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Compositions and methods to treat and control tumors by loading antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 11/583588 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 19244 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037769.pdf [firstpage_image] =>[orig_patent_app_number] => 11583588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095571 [patent_doc_number] => 20070117180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme' [patent_app_type] => utility [patent_app_number] => 11/542180 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12469 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117180.pdf [firstpage_image] =>[orig_patent_app_number] => 11542180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7741099 [patent_doc_number] => 08106176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Matrix metalloproteinase 11 vaccine' [patent_app_type] => utility [patent_app_number] => 12/083031 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 31 [patent_no_of_words] => 18749 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106176.pdf [firstpage_image] =>[orig_patent_app_number] => 12083031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5215638 [patent_doc_number] => 20070104719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Caspase Activated Prodrugs Therapy' [patent_app_type] => utility [patent_app_number] => 11/537578 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17966 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104719.pdf [firstpage_image] =>[orig_patent_app_number] => 11537578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538849 [patent_doc_number] => 20100221773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/992634 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16003 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221773.pdf [firstpage_image] =>[orig_patent_app_number] => 11992634 [rel_patent_id] =>[rel_patent_doc_number] =>)